213 related articles for article (PubMed ID: 16310573)
1. Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies.
Aranda P; Segura J; Ruilope LM; Aranda FJ; Frutos MA; López V; López de Novales E
Am J Kidney Dis; 2005 Dec; 46(6):1074-9. PubMed ID: 16310573
[TBL] [Abstract][Full Text] [Related]
2. Renoprotective effect of telmisartan in patients with chronic kidney disease.
Nakamura T; Inoue T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Node K
Clin Exp Hypertens; 2008 Oct; 30(7):662-72. PubMed ID: 18855269
[TBL] [Abstract][Full Text] [Related]
3. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
Galle J; Schwedhelm E; Pinnetti S; Böger RH; Wanner C;
Nephrol Dial Transplant; 2008 Oct; 23(10):3174-83. PubMed ID: 18450829
[TBL] [Abstract][Full Text] [Related]
4. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
[TBL] [Abstract][Full Text] [Related]
5. Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease.
Rysavá R; Tesar V; Merta M;
Blood Press Monit; 2005 Aug; 10(4):207-13. PubMed ID: 16077267
[TBL] [Abstract][Full Text] [Related]
6. Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.
Tylicki L; Renke M; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2008; 42(4):381-8. PubMed ID: 19230172
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.
Weinbergová O; Metelka R; Vymetal J; Konecný K; Kosatíková Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Jul; 148(1):69-73. PubMed ID: 15523550
[TBL] [Abstract][Full Text] [Related]
8. Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria.
Fogari R; Derosa G; Zoppi A; Preti P; Lazzari P; Destro M; Fogari E; Rinaldi A; Mugellini A
Am J Hypertens; 2007 Apr; 20(4):417-22. PubMed ID: 17386350
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan in patients with mild/moderate hypertension and chronic kidney disease.
Sharma AM; Hollander A; Köster J; ;
Clin Nephrol; 2005 Apr; 63(4):250-7. PubMed ID: 15847251
[TBL] [Abstract][Full Text] [Related]
10. Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
Nakamura T; Inoue T; Suzuki T; Kawagoe Y; Ueda Y; Koide H; Node K
Hypertens Res; 2008 May; 31(5):841-50. PubMed ID: 18712038
[TBL] [Abstract][Full Text] [Related]
11. The telmisartan renoprotective study from incipient nephropathy to overt nephropathy--rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study.
Makino H; Haneda M; Babazono T; Moriya T; Ito S; Iwamoto Y; Kawamori R; Takeuchi M; Katayama S
J Int Med Res; 2005; 33(6):677-86. PubMed ID: 16372586
[TBL] [Abstract][Full Text] [Related]
12. Prevention of loss of renal function over time in patients with diabetic nephropathy.
Barnett A
Am J Med; 2006 May; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
[TBL] [Abstract][Full Text] [Related]
13. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
[TBL] [Abstract][Full Text] [Related]
14. Renoprotective effects of telmisartan in patients with advanced chronic kidney disease.
Tokunaga M; Kabashima N; Serino R; Shibata T; Matsumoto M; Miyamoto T; Miyazaki M; Furuno Y; Nakamata J; Fujimoto Y; Takeuchi M; Abe H; Okazaki M; Otsuji Y; Tamura M
Clin Nephrol; 2010 Feb; 73(2):139-46. PubMed ID: 20129021
[TBL] [Abstract][Full Text] [Related]
15. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
Nakamura T; Fujiwara N; Kawagoe Y; Sugaya T; Ueda Y; Koide H
Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070
[TBL] [Abstract][Full Text] [Related]
16. Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial.
Barnett A
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S132-5. PubMed ID: 16565237
[TBL] [Abstract][Full Text] [Related]
17. A pilot study for evaluation of the efficacy and safety of telmisartan in reducing microalbuminuria in hypertensive patients with type 2 diabetes mellitus.
Kulkarni RB; Kulkarni BN; Hariharan RS; Naikwadi A; Gawde A; Baliga V; Desai A
J Indian Med Assoc; 2005 Mar; 103(3):187-91. PubMed ID: 16173297
[TBL] [Abstract][Full Text] [Related]
18. Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
Krairittichai U; Chaisuvannarat V
J Med Assoc Thai; 2009 May; 92(5):611-7. PubMed ID: 19459520
[TBL] [Abstract][Full Text] [Related]
19. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
[TBL] [Abstract][Full Text] [Related]
20. Effect of telmisartan on renal outcomes: a randomized trial.
Mann JF; Schmieder RE; Dyal L; McQueen MJ; Schumacher H; Pogue J; Wang X; Probstfield JL; Avezum A; Cardona-Munoz E; Dagenais GR; Diaz R; Fodor G; Maillon JM; Rydén L; Yu CM; Teo KK; Yusuf S;
Ann Intern Med; 2009 Jul; 151(1):1-10, W1-2. PubMed ID: 19451556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
